Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719910 | SCV000724100 | likely benign | not provided | 2021-02-19 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000660160 | SCV000782154 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000864876 | SCV001005747 | benign | Adams-Oliver syndrome 5 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000143941 | SCV001333785 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-06-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000864876 | SCV002554453 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269926 | SCV002554454 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000143941 | SCV004990172 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-03-16 | criteria provided, single submitter | clinical testing | The c.3901+3G>A intronic alteration consists of a G to A substitution nucleotides after coding exon 23 in the NOTCH1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Blueprint Genetics | RCV000143940 | SCV000188818 | likely benign | Marfan syndrome | 2014-12-31 | no assertion criteria provided | clinical testing | |
Blueprint Genetics | RCV000143941 | SCV000188819 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2014-12-31 | no assertion criteria provided | clinical testing |